Pediatric arrhythmias: which are the news?
Knowledge about cardiac arrhythmias has significantly improved in the last 20 years, and the improvements in diagnosis and in therapy have also had important effects on the management of pediatric arrhythmias. In this paper, the most important developments in the field of management of pediatric arrhythmias (fetal arrhythmias, genetics, pharmacological strategies, radiofrequency ablation, new technologies) as well as the remaining problems (risk stratification of some arrhythmic forms as for example Wolff-Parkinson-White and ventricular arrhythmias) will be discussed.
Vignati
Gabriele
G
Pediatric Cardiology, Niguarda Hospital, Piazza Ospedale Maggiore, Milan, Italy. cardioped@ospedaleniguarda.it
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000601:surgery / Q000628:therapy*; D017115:Catheter Ablation / Q000379:methods*; D002648:Child; D004452:Echocardiography / Q000379:methods; D022062:Electrophysiologic Techniques, Cardiac; D005315:Fetal Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000601:surgery / Q000628:therapy*; D020022:Genetic Predisposition to Disease; D006801:Humans; D009154:Mutation; D012307:Risk Factors; D013617:Tachycardia, Supraventricular / Q000628:therapy; D016216:Ultrasonography, Prenatal
D000889:Anti-Arrhythmia Agents